Skip to main content

MECANISMOS DE ADAPTACION DE LA LEVADURA PATOGENA CRYPTOCOCCUS NEOFORMANS AL PULMON Y NUEVAS TERAPIAS

PID2020-114546RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre INSTITUTO DE SALUD CARLOS III DE MADRID (ISCIII)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Broad Protection against Invasive Fungal Disease from a Nanobody Targeting the Active Site of Fungal β-1,3-Glucanosyltransferases

  • Redrado-Hernández, Sergio
  • Macías-León, Javier
  • Castro-López, Jorge
  • Belén Sanz, Ana
  • Dolader, Elena
  • Arias, Maykel
  • González-Ramírez, Andrés Manuel
  • Sánchez-Navarro, David
  • Petryk, Yuliya
  • Farkaš, Vladimír
  • Vincke, Cécile
  • Muyldermans, Serge
  • Garcia-Barbazan, Irene
  • Del Agua, Celia
  • Zaragoza, Oscar
  • Arroyo, Javier
  • Pardo, Julián
  • Gálvez, Eva M
  • Hurtado-Guerrero, Ramon
  • Redrado-Hernández, Sergio
  • Macías-León, Javier
  • Castro-López, Jorge
  • Belén Sanz, Ana
  • Dolader, Elena
  • Arias, Maykel
  • González-Ramírez, Andrés Manuel
  • Sánchez-Navarro, David
  • Petryk, Yuliya
  • Farkaš, Vladimír
  • Vincke, Cécile
  • Muyldermans, Serge
  • Del Agua, Celia
  • Zaragoza, Oscar
  • Arroyo, Javier
  • Pardo, Julián
  • Gálvez, Eva M
  • Hurtado-Guerrero, Ramon
Invasive fungal disease accounts for about 3.8 million deaths annually, an unacceptable rate that urgently prompts the discovery of new knowledge-driven treatments. We report the use of camelid single-domain nanobodies (Nbs) against fungal β-1,3-glucanosyltransferases (Gel) involved in β-1,3-glucan transglycosylation. Crystal structures of two Nbs with Gel4 from Aspergillus fumigatus revealed binding to a dissimilar CBM43 domain and a highly conserved catalytic domain across fungal species, respectively. Anti-Gel4 active site Nb3 showed significant antifungal efficacy in vitro and in vivo prophylactically and therapeutically against different A. fumigatus and Cryptococcus neoformans isolates, reducing the fungal burden and disease severity, thus significantly improving immunocompromised animal survival. Notably, C. deneoformans (serotype D) strains were more susceptible to Nb3 and genetic Gel deletion than C. neoformans (serotype A) strains, indicating a key role for β-1,3-glucan remodelling in C. deneoformans survival. These findings add new insight about the role of β-1,3-glucan in fungal biology and demonstrate the potential of nanobodies in targeting fungal enzymes to combat invasive fungal diseases.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Identification of small molecules with virus growth enhancement properties

  • García-Murria, Maria Jesús
  • Gadea-Salom, Laura
  • Moreno, Sandra
  • Zaragoza, Óscar
  • Brun Torres, Alejandro
  • Mingarro, Ismael
  • Martínez-Gil, Luis
The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused the pandemic disease known as coronavirus disease 2019 (COVID-19). COVID-19 vaccines were developed at record speed and were authorized approximately a year after the original outbreak. This fast response saved the lives of countless individuals and reduced the disease burden of many more. The experience has served as a reminder of the necessity to implement solid vaccine development platforms and fast production pipelines. Manufacturing vaccines for enveloped viruses, including some SARS-CoV-2 vaccines, often relies on the production of large quantities of viruses in vitro. Thus, speeding up or increasing virus production would expedite vaccine development. With this objective in mind, we established a high throughput screening (HTS) to identify small molecules that enhance or speed up host-virus membrane fusion. Among the HTS hits, we identified that ethynylestradiol augments SARS-CoV-2 fusion activity in both the absence and presence of TMPRSS2. Furthermore, we confirmed that ethynylestradiol can boost the growth of not only SARS-CoV-2 but also Influenza A virus in vitro. A small molecule with these characteristics could be implemented to improve vaccines production., We thank the Generalitat Valenciana (PROMETEO/2019/065) and the Spanish Ministry of Science and Innovation (PID2020-119111GB-I00). We thank P. Selvi for excellent technical assistance. O.Z. is funded by grant PID2020-114546RB-I00 from National Research Agency (Spanish Ministry for Science and Innovation). This publication was also supported by the European Virus Archive GLOBAL (EVA-GLOBAL) project which has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement 871029., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Identification of small molecules capable of enhancing viral membrane fusion

  • García-Murria, Maria Jesús
  • Gadea-Salom, Laura
  • Moreno, Sandra
  • Rius-Salvador, Marina
  • Zaragoza, Óscar
  • Brun Torres, Alejandro
  • Mingarro, Ismael
  • Martínez-Gil, Luis
12 Pág., Several approaches have been developed to analyze the entry of highly pathogenic viruses. In this study, we report the implementation of a Bimolecular Multicellular Complementation (BiMuC) assay to safely and efficiently monitor SARS-CoV-2 S-mediated membrane fusion without the need for microscopy-based equipment. Using BiMuC, we screened a library of approved drugs and identified compounds that enhance S protein-mediated cell-cell membrane fusion. Among them, ethynylestradiol promotes the growth of SARS-CoV-2 and Influenza A virus in vitro. Our findings demonstrate the potential of BiMuC for identifying small molecules that modulate the life cycle of enveloped viruses, including SARS-CoV-2., This work was supported by the Generalitat Valenciana (PROMETEO/2019/065) and grant PID2020-119111GB-I00 by MCIN/AEI/10.13039/501100011033. O.Z. is funded by grant PID2020-114546RB by MCIN/AEI/10.13039/501100011033. L.G. is the recipient of a predoctoral contract (CIACIF/2021/119) from the Generatitat Valenciana. M.R-S is the recipient of a predoctoral contract from the Spanish Ministry of Science and Innovation (PRE2021-101042 by MCIN/AEI/10.13039/501100011033). This publication was also supported by the European Virus Archive GLOBAL (EVA-GLOBAL) project which has received funding from the European Union?s Horizon 2020 research and innovation program under grant agreement 871029., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Resistance to Azoles in Candida parapsilosis Isolates from Spain Is Associated with an Impairment in Filamentation and Biofilm Formation

  • Torres-Cano, Alba
  • Armentia, Cristina de
  • Roldán, Alejandra
  • López Peralta, Elena
  • Manosalva, Juliana
  • Merino-Amador, Paloma
  • González-Romo, Fernando
  • Puig-Asensio, Mireia
  • Ardanuy, Carmen
  • Martín-Gómez, María Teresa
  • Romero Herrero, Daniel
  • Pérez Ayala, Ana
  • López Lomba, Marta
  • Durán Valle, María Teresa
  • Sánchez-Romero, Isabel
  • Muñoz-Algarra, María
  • Roiz Mesones, María Pía
  • Lara Plaza, Isabel
  • Ruiz-Pérez de Pipaón, Maite
  • Megías Lobón, Gregoria
  • Mantecón Vallejo, María Ángeles
  • Alcázar Fuoli, Laura
  • Megías, Diego
  • Zaragoza, Oscar
In recent years, there has been an increase in the incidence of fluconazole-non-susceptible (FNS) Candida parapsilosis. The reasons why these strains are able to colonize hospitals remain unknown. It is also unclear whether these strains exhibit resistance to the disinfectants used in hospitals, facilitating their spread. For these reasons, in this work, we aimed to investigate whether fluconazole resistance was associated with virulence traits and the resistance of these strains to common hospital disinfectants. The general conclusion of the study was that more than 95% of the FNS strains, regardless of the resistance mutation they carried, had filamentation problems, whereas around 75% of the susceptible strains formed pseudohyphae and were capable of filamentation. This 95% of the FNS strains did not form pseudohyphae, did not invade agar, and did not form biofilms, while the susceptible strains exhibited the opposite behaviour. Through microfluidics experiments, we observed that both the susceptible and FNS strains were capable of adhering to a plastic surface under dynamic conditions, but the FNS strains formed unstable aggregates that did not remain attached to the surface, confirming the filamentation defect of these strains. In the second part of the study, we observed that FNS strains are susceptible to clinical disinfectants, although they presented a slight resistance to some of them, such as chlorhexidine, compared to susceptible isolates. In this work, we address important aspects to understand the dissemination of FNS strains in clinical outbreaks., This work has been sponsored by a non-restricted grant by Gilead Sciences. O.Z. was funded by grant PID2020-114546RB by MCIN/AEI/10.13039/501100011033. A.T.-C. was funded by the ministry for Science and Innovation (contract FPI PRE2021-099486). E.L.-P. was funded by a predoctoral contract of the Autonomous Community of Madrid (Reference PIPF-2022/SAL-GL-24953)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the OVID-19 Pandemic

  • Trevijano-Contador, Nuria
  • Torres-Cano, Alba
  • Carballo-González, Cristina
  • Puig-Asensio, Mireia|||0000-0002-0722-2218
  • Martin-Gomez, M. Teresa|||0000-0001-8119-8749
  • Jiménez-Martínez, Emilio|||0000-0003-2831-037X
  • Romero, Daniel|||0000-0003-4934-2477
  • Nuvials, Xavier|||0000-0002-6648-2394
  • Olmos-Arenas, Roberto
  • Moretó-Castellsagué, María Clara
  • Fernández-Delgado, Lucía|||0000-0001-8815-0967
  • Rodríguez-Sevilla, Graciela
  • Aguilar-Sánchez, María-Mercedes
  • Ayats, Josefina
  • Ardanuy, Carmen|||0000-0003-0225-607X
  • Sánchez Romero, María Isabel
  • Muñoz-Algarra, María
  • Merino-Amador, Paloma
  • González-Romo, Fernando
  • Megías-Lobón, Gregoria
  • García-Campos, Jose Angel
  • Mantecón-Vallejo, María Ángeles
  • Alcoceba, Eva
  • Escribano Martos, Pilar|||0000-0001-6254-4570
  • Guinea, Jesús
  • Durán-Valle, Maria Teresa
  • Fraile-Torres, Arturo
  • Roiz-Mesones, María Pía
  • Lara-Plaza, Isabel
  • de Ayala, Ana Pérez
  • Simón Sacristán, María|||0009-0008-9585-2156
  • Collazos-Blanco, Ana
  • Nebreda-Mayoral, Teresa
  • March-Roselló, Gabriel
  • Alcázar-Fuoli, Laura
  • Zaragoza, Óscar|||0000-0002-1581-0845
Candida parapsilosis is a frequent cause of candidemia worldwide. Its incidence is associated with the use of medical implants, such as central venous catheters or parenteral nutrition. This species has reduced susceptibility to echinocandins, and it is susceptible to polyenes and azoles. Multiple outbreaks caused by fluconazole-nonsusceptible strains have been reported recently. A similar trend has been observed among the C. parapsilosis isolates received in the last 2 years at the Spanish Mycology Reference Laboratory. Yeast were identified by molecular biology, and antifungal susceptibility testing was performed using the European Committee on Antimicrobial Susceptibility Testing protocol. The ERG11 gene was sequenced to identify resistance mechanisms, and strain typing was carried out by microsatellite analysis. We examined the susceptibility profile of 1315 C. parapsilosis isolates available at our reference laboratory between 2000 and 2021, noticing an increase in the number of isolates with acquired resistance to fluconazole, and voriconazole has increased in at least 8 different Spanish hospitals in 2020-2021. From 121 recorded clones, 3 were identified as the most prevalent in Spain (clone 10 in Catalonia and clone 96 in Castilla-Leon and Madrid, whereas clone 67 was found in 2 geographically unrelated regions, Cantabria and the Balearic Islands). Our data suggest that concurrently with the coronavirus disease 2019 pandemic, a selection of fluconazole-resistant C. parapsilosis isolates has occurred in Spain, and the expansion of specific clones has been noted across centers. Further research is needed to determine the factors that underlie the successful expansion of these clones and their potential genetic relatedness.